Deep Track Capital Increases Stake to 11.7% in LB Pharmaceuticals via Private Placement
LBRX sits 81% above its 52-week low of $13.36.
Summary
Deep Track Capital, a significant institutional investor, has increased its beneficial ownership in LB Pharmaceuticals to 11.7% by participating in a recent private placement, acquiring pre-funded warrants valued at approximately $10 million.
Key Events · Ownership and Investor Activity · LBRX
-
Increased Beneficial Ownership
Deep Track Capital's aggregate beneficial ownership in LB Pharmaceuticals Inc. has increased to 11.7% of outstanding common stock, up from a previously reported stake.
-
Private Placement Participation
Deep Track Capital entities acquired 472,369 pre-funded warrants in a private placement that closed on February 6, 2026, representing an investment of approximately $10 million. This follows the company's 8-K announcement on February 5, 2026, regarding the $100 million private placement.
-
Warrant Exercise Limitation
The acquired pre-funded warrants include a 9.99% ownership limitation, preventing immediate exercise if it would cause the holder's beneficial ownership to exceed this threshold.
-
Registration Rights Agreement
In connection with the private placement, the company entered into a Registration Rights Agreement, obligating it to register the shares underlying the warrants for resale within 60 days.
Analysis · LBRX · Life Sciences
This Schedule 13D/A provides updated details on Deep Track Capital's significant stake in LB Pharmaceuticals following their participation in the recently announced private placement. Their investment of approximately $10 million in pre-funded warrants, which was previously disclosed in a Form 4, demonstrates continued confidence from a major institutional investor. While the private placement itself is dilutive and was priced at a discount to the current market, securing capital from a key investor is crucial for the company's operations, especially given the prior 8-K announcement of a $100 million raise to fund a pivotal program. The 9.99% ownership limitation on the warrants is a notable detail, managing the immediate potential for further dilution from these specific securities.
How filings like this one have moved
In the 30 days to Sep 18, 2026, 29.1% of the 1692 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.38%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LBRX was trading at $24.22 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $612.7M. The 52-week trading range was $13.36 to $24.95. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.